Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Scientists hunt for lupus genes in kids

NCT ID NCT01992666

Knowledge-focused Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at genetic and immune system differences in children with lupus, a chronic autoimmune disease. Researchers collected blood samples from 271 participants to search for mutations in known lupus genes and discover new ones. The goal is to better understand what causes lupus in young people and how genetics play a role.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could identify new genes linked to lupus, leading to better understanding and potential targets for future treatments.
What could go wrong
This is an observational study, not a treatment trial. It may not directly benefit participants, and findings may not apply to all lupus patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

271 people

The number who actually took part.

Start date

Oct 2013

Finished

Oct 2016

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Male or female subject, major or minor of any age with SLE (defined according to the ACR criteria) * Onset pediatric (\<18 years) OR * Syndromic Lupus (associated with growth retardation, neurological deficit not related to lupus, frostbite, lymphoproliferation, the kidney malformations, heart, lung, brain calcifications) OR * Lupus in context with familial consanguinity OR * Familial cases (2 cases of SLE related first degree relative) OR related topic of the first degree to a lupus patient participant (if family lupus or related parents) OR * mother/father's lupus patient (in cas of simplex lupus) 2. A person or beneficiary entitled to a social security scheme or similar 3. Informed consent signed by the person (or parent / holding parental authority for minors) Exclusion Criteria: \- none

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Systemic lupus erythematosus (SLE) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

systemic lupus erythematosus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Systemic lupus erythematosus (SLE)

Contacts and locations

Locations

  • Centre de néphrologie et de transplantation rénale - Hôpital de la conception

    Marseille, France

  • Hôpital Femme Mère Enfant

    Bron, France

  • Hôpital Nord

    Saint-Etienne, France

  • Médecine Interne Adulte - Centre Hospitalier Lyon Sud

    Pierre-Bénite, 69495, France

  • Néphrologie Pédiatrique - CHU Besançon

    Besançon, France

  • Service d'hématologie / oncologie pédiatrique - CHU

    Angers, France

  • Service d'immunologie et rhumatologie pédiatrique - Centre de référence de maladies rhumatologiques et inflammatoires rares en pédiatrie-Hôpital Necker-Enfants malades

    Paris, France

  • Service de Néphrologie - Hôpital Edouard Herriot

    Lyon, France

  • Service de Néphrologie Pédiatrique

    Clermont-Ferrand, France

  • Service de Néphrologie et Rhumatologie Pédiatrique

    Grenoble, France

  • Service de Pédiatrie Générale - CHU Réunion

    Saint-Pierre, France

  • Service de Rhumatologie - Centre Hospitalier Lyon Sud

    Pierre-Bénite, France

  • Service de Rhumatologie Pédiatrique - Hôpital de Bicêtre

    Le Kremlin-Bicêtre, France

  • Service de médecine infantile- Hôpital Nord

    Marseille, France

  • Service de médecine interne - Centre de référence des maladies rares

    Lille, France

  • Service de médecine interne - Hôpital Saint Antoine

    Paris, France

  • Service de médecine interne - Hôpitaux privés de Metz

    Metz, France

  • Service de néphrologie - médecine interne - Hypertension pédiatrique - Hôpital des enfants

    Toulouse, France

  • Service de néphrologie pédiatrique - CHU de Nantes

    Nantes, France

  • Service de néphrologie, endocrinologie, maladie métabolique et hématologie bénigne pédiatriques - Hôpital Jeanne de Flandre

    Lille, France

  • Service de pédiatrie - CHU Fort de France

    Fort de France, France

  • Service de pédiatrie générale - Hôpital Robert-Debré

    Paris, France

  • Service médecine infantile 2

    Nancy, France

  • Service pédiatrie grands enfants-adolescents - CHU Hôpital Sud

    Rennes, France

  • ervice d'urgence et post-urgences pédiatriques - CHU Arnaud de Villeneuve

    Montpellier, France

  • édiatrie générale, urgences et maladies infectieuses, Hôpital Salengro

    Lille, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.